Literature DB >> 24989244

Re: "Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts".

Alan R Lifson1, Ray Nelson2, Ronald J Prineas3, Daniel Duprez4.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24989244      PMCID: PMC4128775          DOI: 10.1093/aje/kwu165

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  7 in total

1.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Fred S Apple; Marcello Galvani; Hugo A Katus; L Kristin Newby; Jan Ravkilde; Bernard Chaitman; Peter M Clemmensen; Mikael Dellborg; Hanoch Hod; Pekka Porela; Richard Underwood; Jeroen J Bax; George A Beller; Robert Bonow; Ernst E Van der Wall; Jean-Pierre Bassand; William Wijns; T Bruce Ferguson; Philippe G Steg; Barry F Uretsky; David O Williams; Paul W Armstrong; Elliott M Antman; Keith A Fox; Christian W Hamm; E Magnus Ohman; Maarten L Simoons; Philip A Poole-Wilson; Enrique P Gurfinkel; José-Luis Lopez-Sendon; Prem Pais; Shanti Mendis; Jun-Ren Zhu; Lars C Wallentin; Francisco Fernández-Avilés; Kim M Fox; Alexander N Parkhomenko; Silvia G Priori; Michal Tendera; Liisa-Maria Voipio-Pulkki; Alec Vahanian; A John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Joao Morais; Sorin Brener; Robert Harrington; David Morrow; Michael Lim; Marco A Martinez-Rios; Steve Steinhubl; Glen N Levine; W Brian Gibler; David Goff; Marco Tubaro; Darek Dudek; Nawwar Al-Attar
Journal:  Circulation       Date:  2007-10-19       Impact factor: 29.690

2.  Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.

Authors:  H M Crane; S R Heckbert; D R Drozd; M J Budoff; J A C Delaney; C Rodriguez; P Paramsothy; W B Lober; G Burkholder; J H Willig; M J Mugavero; W C Mathews; P K Crane; R D Moore; S Napravnik; J J Eron; P Hunt; E Geng; P Hsue; G S Barnes; J McReynolds; I Peter; C Grunfeld; M S Saag; M M Kitahata
Journal:  Am J Epidemiol       Date:  2014-03-11       Impact factor: 4.897

3.  Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.

Authors:  Abdel G Babiker; Sean Emery; Gerd Fätkenheuer; Fred M Gordin; Birgit Grund; Jens D Lundgren; James D Neaton; Sarah L Pett; Andrew Phillips; Giota Touloumi; Michael J Vjechaj
Journal:  Clin Trials       Date:  2012-04-30       Impact factor: 2.486

4.  Interleukin-2 therapy in patients with HIV infection.

Authors:  D Abrams; Y Lévy; M H Losso; A Babiker; G Collins; D A Cooper; J Darbyshire; S Emery; L Fox; F Gordin; H C Lane; J D Lundgren; R Mitsuyasu; J D Neaton; A Phillips; J P Routy; G Tambussi; D Wentworth
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

Review 5.  The role of HIV in serious diseases other than AIDS.

Authors:  Andrew N Phillips; James Neaton; Jens D Lundgren
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

6.  Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Authors:  Alan R Lifson; Waldo H Belloso; Richard T Davey; Daniel Duprez; Jose M Gatell; Jennifer F Hoy; Eric A Krum; Ray Nelson; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James H Sampson; John Worley
Journal:  HIV Clin Trials       Date:  2010 Jul-Aug

7.  Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

Authors:  Christopher J Miller; Jason V Baker; Alison M Bormann; Kristine M Erlandson; Katherine Huppler Hullsiek; Amy C Justice; Jacqueline Neuhaus; Roger Paredes; Kathy Petoumenos; Deborah Wentworth; Alan Winston; Julian Wolfson; James D Neaton
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

  7 in total
  1 in total

1.  The authors reply.

Authors:  H M Crane; S R Heckbert; D R Drozd; M J Budoff; J A C Delaney; C Rodriguez; P Paramsothy; W B Lober; G Burkholder; J H Willig; M J Mugavero; W C Mathews; P K Crane; R D Moore; S Napravnik; J J Eron; P Hunt; E Geng; P Hsue; G S Barnes; J McReynolds; I Peter; C Grunfeld; M S Saag; M M Kitahata
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.